logo

For the Inventor, By the Inventor

Shanghai, China

Jinming Gu

This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Changzhou Hansoh Pharmaceutical Co., Ltd.. Active years: 2021-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jinming Gu. Retrieved from https://idiyas.com/inventor/jinming-gu-tkivl3pk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal3 out of 159 
 
Jiangsu Hengrui Medicine Company Ltd.
 patents
silverMedal3 out of 100 
 
Shanghai Hengrui Pharmaceutical Co., Ltd.
 patents
bronzeMedal1 out of 2 
 
Changzhou Hansoh Pharmaceutical Co., Ltd.
 patents
4. 1 out of 1 
 
Hansoh (Shanghai) Healthtech Co., Ltd.
 patent
where one patent can have more than one assignee

Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):Explore Patents
1. 11680100 - B7-H3 antibody, antigen-binding fragment thereof and medical use thereof (2023-06-20),
2. 11359021 - PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof (2022-06-14),
3. 11274142 - Fusion protein containing TGF-β receptor and medicinal uses thereof (2022-03-15),
4. 10899837 - B7-H3 antibody, antigen-binding fragment thereof and medical use thereof (2021-01-26),

Title: The Innovative Contributions of Jinming Gu

Introduction

Jinming Gu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the development of antibodies for therapeutic use. With a total of four patents to his name, Gu's work has the potential to impact the treatment of various diseases.

Latest Patents

Among his latest patents is the development of a B7-H3 antibody, along with an antigen-binding fragment and its medical applications. This patent describes a pharmaceutical composition that includes the B7-H3 antibody or its fragments, aimed at treating B7-H3-associated diseases. Another notable patent is for a novel PD-L1 antibody and its antigen-binding fragment, which also includes pharmaceutical uses. This humanized antibody is designed for the treatment of diseases associated with PD-L1, showcasing Gu's innovative approach to antibody development.

Career Highlights

Jinming Gu has worked with notable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of medical innovations.

Collaborations

Throughout his career, Gu has collaborated with esteemed colleagues such as Weikang Tao and Xiaohua Wang. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented technologies.

Conclusion

Jinming Gu's contributions to the field of medicine through his innovative patents highlight his role as a significant inventor. His work on antibodies for therapeutic use demonstrates the potential for advancements in treating complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…